Evidence map›Paper›PMID 35680713›Full record

ArticleGeroScience2022

Inhibition of the 3-mercaptopyruvate sulfurtransferase-hydrogen sulfide system promotes cellular lipid accumulation.

Giovanna Casili, Elisa Randi, Theodora Panagaki, Karim Zuhra, Maria Petrosino, Csaba Szabo

Open access · hybridAbstract read
In one paragraph

Article in GeroScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Hydrogen Sulfide in Adipose Tissue Biology.Handbook of experimental pharmacology · 2026
    Review
  3. Crosstalk Between HHandbook of experimental pharmacology · 2026
    Review
  4. HFrontiers in cell and developmental biology · 2026
    Review
  5. A Slow Hydrogen Sulfide Donor GYY-4137 Partially Improves Vascular Function in Spontaneously Hypertensive Rats Fed a High-Fat Diet.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease.International journal of molecular sciences · 2023
    Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Giovanna CasiliChair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musée 18, 1700, Fribourg, Switzerland.
Elisa RandiChair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musée 18, 1700, Fribourg, Switzerland.
Theodora PanagakiChair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musée 18, 1700, Fribourg, Switzerland.
Karim ZuhraChair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musée 18, 1700, Fribourg, Switzerland.
Maria PetrosinoChair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musée 18, 1700, Fribourg, Switzerland.
Csaba SzaboChair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musée 18, 1700, Fribourg, Switzerland. csaba.szabo@unifr.ch.ORCID 0000-0003-3110-4235
University of Fribourg · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

H

Indexed as

Hydrogen SulfideLipidsMorpholinesOrganothiophosphorus CompoundsSulfurtransferases3-mercaptopyruvate sulphurtransferaseGYY 4137Hydrogen SulfideLipidsMorpholinesOrganothiophosphorus CompoundsSulfurtransferases3-Mercaptopyruvate sulfurtransferaseAdipocytesHydrogen sulfideObesity

Identifiers

PMID35680713
PMCPMC9616987
OpenAlexW4281763628

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.